NCT03373539View on ClinicalTrials.gov

Neurotrophin Expression in Infants as a Predictor of Respiratory and Neurodevelopmental Outcomes

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Bronchopulmonary DysplasiaChronic Lung Disease
Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT03373539 - Neurotrophin Expression in Infants as a Predictor of Respiratory and Neurodevelopmental Outcomes | Biotech Hunter | Biotech Hunter